Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit
September 19, 2024 16:30 ET
|
Supernus Pharmaceuticals, Inc.
ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of...
Novo Nordisk A/S: Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function
September 19, 2024 15:10 ET
|
Novo Nordisk A/S
Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function Wegovy® (semaglutide 2.4 mg) is the first...
Perdue Strike Out Hunger Challenge with Delmarva Shorebirds Generates Record 688,000 Meal Equivalents for Hunger Relief
September 19, 2024 12:44 ET
|
Perdue Farms
Salisbury, MD, Sept. 19, 2024 (GLOBE NEWSWIRE) -- As part of Perdue Farms’ commitment to help alleviate food insecurity, the company teamed with the Delmarva Shorebirds Class A minor league baseball...
Innovative Cellular Therapeutics Announces the Publication of Groundbreaking GCC19CART™ Study to Treat mCRC in JAMA Oncology
September 19, 2024 12:09 ET
|
Innovative Cellular Therapeutics
ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics, Inc. (ICT), a clinical-stage biotechnology company developing a comprehensive portfolio of chimeric antigen...
Precede Biosciences Presents Data on Liquid Biopsy Comprehensive Epigenomic Profiling of MS Patients at ECTRIMS 2024
September 19, 2024 10:50 ET
|
Precede Biosciences, Inc.
Precede Biosciences Presents Data on Liquid Biopsy Comprehensive Epigenomic Profiling of MS Patients at ECTRIMS 2024
Thought Leadership & Innovation Foundation Announces Partnership with Paradigm to Support Limb Loss and Preservation Registry
September 19, 2024 10:20 ET
|
Thought Leadership & Innovation Foundation
TLI Reaffirms Partnership with Paradigm to Advance Limb Loss and Preservation Care
Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th
September 19, 2024 10:00 ET
|
Bright Minds Biosciences
Bright Minds Biosciences will host the Key Opinion Leader event with leading experts in epilepsy research and treatment on September 25
Immix Biopharma Announces Dr. Raymond Comenzo, Internationally Recognized AL Amyloidosis Expert, Director of the Myeloma and Amyloid Program at Tufts Medical Center, Joins Scientific Advisory Board
September 19, 2024 09:31 ET
|
Immix Biopharma, Inc.
Dr. Comenzo was the senior author of the landmark Andromeda trial results published in the New England Journal of Medicine in 2021, resulting in the first FDA-approved therapy for AL...
Aembit Unveils 2024 Survey Report Highlighting Major Gaps in Securing Non-Human Identities
September 19, 2024 09:00 ET
|
Aembit
SILVER SPRING, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Aembit, the non-human identity and access management (IAM) company, today released its 2024 Non-Human Identity Security Report, a definitive...
MDA Awards $500,000 Grant to Accelerate ALS Research Through the HEALEY ALS Platform Trial at Massachusetts General Hospital
September 19, 2024 09:00 ET
|
Muscular Dystrophy Association
New York, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) is proud to announce a new clinical research grant of $500,000 over three years, awarded to Sabrina Paganoni,...